Results 301 to 310 of about 2,026,261 (344)

Disease coverage of human genome-wide association studies and pharmaceutical research and development. [PDF]

open access: yesCommun Med (Lond)
Gordillo-Marañón M   +15 more
europepmc   +1 more source

Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy

open access: yesAdvanced Functional Materials, EarlyView.
Porous silicon nanoparticles (PSiNPs) reprogram macrophage endocytosis of manganese@albumin‐based TLR4 nanoagonists, driving TRIF‐biased TLR4 signaling, eliciting robust proinflammatory responses, and potentiating macrophage‐mediated immunotherapeutic effects against NSCLC.
Xiaomei Zhang   +9 more
wiley   +1 more source

Endogenous retroviral solo-LTRs in human genome. [PDF]

open access: yesFront Genet
Chen M   +5 more
europepmc   +1 more source

Microsatellite density landscapes illustrate short tandem repeats aggregation in the complete reference human genome. [PDF]

open access: yesBMC Genomics
Xia Y   +27 more
europepmc   +1 more source

Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing. [PDF]

open access: yesCRISPR J
Waltz M   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

The Human Genome

Science, 2001
Humanity has been given a great gift. With the completion of the human genome sequence, we have received a powerful tool for unlocking the secrets of our genetic heritage and for finding our place among the other participants in the adventure of life.
Donald Kennedy, Barbara R. Jasny
  +8 more sources

Home - About - Disclaimer - Privacy